Modi govt places single largest order of 66 crore Covid-19 vaccine doses, targets to vaccinate 94.4 crore people by December
Indian government placed an order for 66 crores Covid-19 vaccine doses worth Rs 14,505 crore with Serum Institute and Bharat Biotech
As Congress party allies with left parties in Brazil to claim a ‘scam’ in Covaxin deal, here is how the allegations are baseless
Opposition in Brazil forced the govt to cancel Covaxin purchase deal wrongly claiming that it was overpriced and there were irregularities in it
Bharat Biotech releases Phase-3 trials data of Covaxin: Indian-made vaccine 77.8% effective against mild cases, 93% against severe cases
Bharat Biotech announced efficacy analysis data from Phase-3 clinical trials of Covaxin, proved to be highly effective against severe cases of COVID-19
8 European nations accept Covishield in their Green Pass after India’s warning to quarantine their citizens. Details
The EU Digital covid certificate or "Green Pass" will exempt those who are fully vaccinated with a vaccine approved by the EU from mandatory quarantine. The EU "Green Pass" is expected to come into effect from July 1.
US govt’s primary health research institute NIH says Covaxin is highly effective against Alpha and Delta variants of Covid-19
NIH report says that Covaxin generates antibodies that effectively neutralise the Alpha and Delta variants of Sars-CoV-2
India secures milestone in Coronavirus vaccination drive, administers over 86 lakh doses in a single day: Details
CoWIN app showed that Madhya Pradesh administered a whopping 13,71,180 lakh vaccine doses alone on Monday.
Congress leader spreads vaccine hesitancy again, this time claims newborn calves are slaughtered for their serum. Here is the truth
Covaxin does not contain newborn calf serum. It was used for development of cells to replicate Covid-19 virus in lab to produce vaccine.
US FDA rejects emergency use application for Bharat Biotech’s Covaxin, asks Ocugen to launch additional trial for full approval
The US FDA had asked Ocugen to pursue BLA submission and not Emergency Use Approval(EUA), paving the way for the vaccine's full approval in the United States.
After fanning vaccine hesitancy, The Print blames Telegram, Instagram and Central Govt for growth of anti-vaxxer groups
ThePrint is now blaming groups on Telegram and Instagram for spreading anti-vaxxer rumours among people.
Petition wants Delhi High Court to cancel Center’s approval for Covaxin to conduct trials for 2-18 age group
The petitioner wants Delhi High Court to quash govt notification allowing Covaxin trials for the 2-18 age group.